Internal Medicine, Hematology & Oncology · Easton, PA
NPI
1114956067
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3465 Nazareth Rd, Ste 102
Easton, PA, 18045
Phone (610) 330-2630
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
157,937 services
Medicare patients, 2024
237
Average age 74
Drug cost, 2024
$6.4M
1,288 prescriptions
Company payments, 2025
$5,492
From 63 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hayman S Salib was code J1756 (injection, iron sucrose, 1 mg), 24,902 times for 44 patients. In total Hayman S Salib billed 157,937 services in 149 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 24,902 | 44 | $0.18 | $4,411 |
| J0897 Injection, denosumab, 1 mg | Office | 7,740 | 29 | $20.58 | $159K |
| 96367 Intravenous Infusion, Hydration | Office | 2,010 | 88 | $21.32 | $43K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 2,000 | 24 | $0.07 | $148 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,530 | 15 | $6.60 | $10K |
| 99213 Office E&M - Established | Office | 1,309 | 205 | $67.09 | $88K |
| 36415 Venipuncture Blood Collection | Office | 1,235 | 215 | $8.59 | $11K |
| 85025 Blood Count | Office | 1,198 | 215 | $7.55 | $9,041 |
| 85048 Blood Count | Office | 1,196 | 215 | $2.47 | $2,958 |
| 85046 Blood Count | Office | 1,186 | 214 | $5.45 | $6,459 |
| 83735 Clinical Chemistry | Office | 1,165 | 212 | $6.55 | $7,634 |
| 80053 Clinical Chemistry | Office | 1,164 | 212 | $10.33 | $12K |
| 82248 Clinical Chemistry | Office | 1,164 | 212 | $4.91 | $5,712 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,132 | 20 | $0.09 | $102 |
| 84100 Clinical Chemistry | Office | 1,013 | 212 | $4.64 | $4,697 |
By year: 2022 $2.7M for 232,683 services; 2023 $2.8M for 252,534 services; 2024 $2.1M for 157,937 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,235 | 215 | $8.59 | $11K |
| 85025 Blood Count | 1,198 | 215 | $7.55 | $9,041 |
| 85048 Blood Count | 1,196 | 215 | $2.47 | $2,958 |
| 85046 Blood Count | 1,186 | 214 | $5.45 | $6,459 |
| 83735 Clinical Chemistry | 1,165 | 212 | $6.55 | $7,634 |
| 80053 Clinical Chemistry | 1,164 | 212 | $10.33 | $12K |
| 82248 Clinical Chemistry | 1,164 | 212 | $4.91 | $5,712 |
| 84100 Clinical Chemistry | 1,013 | 212 | $4.64 | $4,697 |
| 83615 Clinical Chemistry | 1,013 | 212 | $5.90 | $5,979 |
| 84550 Clinical Chemistry | 1,003 | 211 | $4.42 | $4,430 |
Medicare prescription drug claims, 2024
In 2024, the drug Hayman S Salib prescribed most often to Medicare patients was Eliquis (Apixaban), with 77 prescriptions and refills. In total Hayman S Salib wrote 1,288 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 77 | 88 | 14 | $51K |
| Procrit Epoetin Alfa | 55 | 55 | 11 | $184K |
| Oxycodone Hcl Generic | 49 | 49 | Under 11 | $333 |
| Calquence Acalabrutinib Maleate | 44 | 44 | Under 11 | $671K |
| Warfarin Sodium Generic | 42 | 114 | Under 11 | $357 |
| Levothyroxine Sodium Generic | 39 | 97 | 14 | $387 |
| Brukinsa Zanubrutinib | 37 | 37 | Under 11 | $547K |
| Pantoprazole Sodium Generic | 30 | 57 | 15 | $247 |
| Lenalidomide Generic | 29 | 29 | Under 11 | $532K |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 28 | 28 | 28 | $5,290 |
| Mirtazapine Generic | 27 | 40 | 13 | $292 |
| Abrysvo Rsv Vacc, Pref A And Pref B/Pf | 27 | 27 | 27 | $7,628 |
| Retacrit Epoetin Alfa-Epbx | 26 | 26 | Under 11 | $45K |
| Neulasta Onpro Pegfilgrastim | 26 | 26 | Under 11 | $313K |
| Ondansetron Odt Ondansetron | 23 | 23 | Under 11 | $932 |
Brand drugs: 654 claims; generic drugs: 634 claims; opioid claims: 56.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hayman S Salib $5,492 ($5,492 in general payments such as food, travel and fees) from 63 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $392.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $392 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $378 |
| Pfizer Inc. PFE | 16 | $322 |
| Janssen Biotech, Inc. JNJ | 11 | $320 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $314 |
| Abbvie Inc. ABBV | 9 | $237 |
| Seagen Inc. PFE | 2 | $200 |
| Incyte Corporation INCY | 8 | $191 |
| Menarini Silicon Biosystems, Inc. | 10 | $170 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.